Literature DB >> 1902567

Neurotrophic protein S100 beta stimulates glial cell proliferation.

R H Selinfreund1, S W Barger, W J Pledger, L J Van Eldik.   

Abstract

Nervous system development involves a coordinated series of events, including regulation of cell proliferation and differentiation by specific extracellular factors. S100 beta is a neurotrophic protein that has been implicated in regulation of cellular proliferation, but direct evidence was lacking. In this report, nanomolar concentrations of S100 beta are shown to stimulate proliferation of rat C6 glioma cells and primary astrocytes. An S100 mutant with a single amino acid change was inactive. S100 beta also stimulated increases in the steady-state levels of c-myc and c-fos protooncogene mRNAs and complemented the effects of platelet-derived growth factor. Two neuroblastoma cell lines did not proliferate in response to S100 beta, suggesting that the mitogenic activity of S100 beta is selective for astroglial cells. These results suggest that S100 beta may be involved in the coordinate development and maintenance of the central nervous system by synchronously stimulating the differentiation of neurons and the proliferation of astroglia.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1902567      PMCID: PMC51490          DOI: 10.1073/pnas.88.9.3554

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  57 in total

1.  Neurotrophic activity of S-100 beta in cultures of dorsal root ganglia from embryonic chick and fetal rat.

Authors:  L J Van Eldik; B Christie-Pope; L M Bolin; E M Shooter; W O Whetsell
Journal:  Brain Res       Date:  1991-03-01       Impact factor: 3.252

2.  Synthesis of S-100 protein in monolayer cultures of rat-glial cells.

Authors:  G Labourdette; A Marks
Journal:  Eur J Biochem       Date:  1975-10-01

Review 3.  S100 beta as a neurotrophic factor.

Authors:  D R Marshak
Journal:  Prog Brain Res       Date:  1990       Impact factor: 2.453

4.  Appearance of a brain specific antigen (th S-100 protein) during human foetal development.

Authors:  J E Zuckerman; H R Herschman; L Levine
Journal:  J Neurochem       Date:  1970-02       Impact factor: 5.372

5.  Clonal cell lines from the rat central nervous system.

Authors:  D Schubert; S Heinemann; W Carlisle; H Tarikas; B Kimes; J Patrick; J H Steinbach; W Culp; B L Brandt
Journal:  Nature       Date:  1974-05-17       Impact factor: 49.962

6.  Synthesis by a clonal line of rat glial cells of a protein unique to the nervous system.

Authors:  S E Pfeiffer; H R Herschman; J Lightbody; G Sato
Journal:  J Cell Physiol       Date:  1970-06       Impact factor: 6.384

7.  Cloning and expression of a developmentally regulated protein that induces mitogenic and neurite outgrowth activity.

Authors:  Y S Li; P G Milner; A K Chauhan; M A Watson; R M Hoffman; C M Kodner; J Milbrandt; T F Deuel
Journal:  Science       Date:  1990-12-21       Impact factor: 47.728

8.  Myristylation alters DNA-binding activity and transactivation of FBR (gag-fos) protein.

Authors:  N Kamata; R M Jotte; J T Holt
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

9.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

10.  Antisense inhibition of glial S100 beta production results in alterations in cell morphology, cytoskeletal organization, and cell proliferation.

Authors:  R H Selinfreund; S W Barger; M J Welsh; L J Van Eldik
Journal:  J Cell Biol       Date:  1990-11       Impact factor: 10.539

View more
  63 in total

1.  Glial protein S100B modulates long-term neuronal synaptic plasticity.

Authors:  Hiroshi Nishiyama; Thomas Knopfel; Shogo Endo; Shigeyoshi Itohara
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

2.  Down-regulation of a member of the S100 gene family in mammary carcinoma cells and reexpression by azadeoxycytidine treatment.

Authors:  S W Lee; C Tomasetto; K Swisshelm; K Keyomarsi; R Sager
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

Review 3.  [Neuromonitoring with S-100 protein in the intensive care unit].

Authors:  M Fries; J Bickenbach; S Beckers; D Henzler; R Rossaint; R Kuhlen
Journal:  Anaesthesist       Date:  2004-10       Impact factor: 1.041

4.  Time dependent alterations of co-localization of S100beta and GFAP in the MPTP-treated mice.

Authors:  T Himeda; Y Watanabe; H Tounai; N Hayakawa; H Kato; T Araki
Journal:  J Neural Transm (Vienna)       Date:  2006-06-01       Impact factor: 3.575

5.  Purification, crystallization and preliminary X-ray diffraction studies on human Ca2+-binding protein S100B.

Authors:  Thorsten Ostendorp; Claus W Heizmann; Peter M H Kroneck; Günter Fritz
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-06-15

6.  Identification and Characterization of DNA Aptamers Specific for Phosphorylation Epitopes of Tau Protein.

Authors:  I-Ting Teng; Xiaowei Li; Hamad Ahmad Yadikar; Zhihui Yang; Long Li; Yifan Lyu; Xiaoshu Pan; Kevin K Wang; Weihong Tan
Journal:  J Am Chem Soc       Date:  2018-10-16       Impact factor: 15.419

7.  Abnormal exploratory behavior in transgenic mice carrying multiple copies of the human gene for S100 beta.

Authors:  R Gerlai; J Roder
Journal:  J Psychiatry Neurosci       Date:  1995-03       Impact factor: 6.186

8.  Overexpression of human S100B exacerbates brain damage and periinfarct gliosis after permanent focal ischemia.

Authors:  Takashi Mori; Jun Tan; Gary W Arendash; Naoki Koyama; Yoshiko Nojima; Terrence Town
Journal:  Stroke       Date:  2008-05-01       Impact factor: 7.914

9.  S100B protein in tissue development, repair and regeneration.

Authors:  Guglielmo Sorci; Francesca Riuzzi; Cataldo Arcuri; Claudia Tubaro; Roberta Bianchi; Ileana Giambanco; Rosario Donato
Journal:  World J Biol Chem       Date:  2013-02-26

10.  S100B inhibition reduces behavioral and pathologic changes in experimental traumatic brain injury.

Authors:  Shruti V Kabadi; Bogdan A Stoica; Danna B Zimmer; Lauriaselle Afanador; Kara B Duffy; David J Loane; Alan I Faden
Journal:  J Cereb Blood Flow Metab       Date:  2015-07-08       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.